Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Bausch Health

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: MOA-728

Study type: Interventional

Funder types: Industry

Identifiers

NCT00434395

3200L2-104

Details and patient eligibility

About

The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Generally healthy subjects men or women aged 18-50

Exclusion criteria

• Any significant clinically important disease
• Family history of long QT syndrome and/or sudden cardiac death
• Allergy to moxifloxacin or the quinolone class of antibiotics

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind